InnovaRx Innova Health Strategies

C86.40

Blastic NK-cell lymphoma not having achieved remission

Billable FY2026 2025-10-01 → 2026-09-30 FY2025–2027 only
Exclusions 4 never code together
C86code
Excludes1
  • anaplastic large cell lymphoma, ALK negative (C84.7-)C84.7-
  • anaplastic large cell lymphoma, ALK positive (C84.6-)C84.6-
  • mature T/NK-cell lymphomas (C84.-)C84.-
  • other specified types of non-Hodgkin lymphoma (C85.8-)C85.8-

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Instructional notes 14
C86.40code
Inclusion terms
  • Blastic NK-cell lymphoma NOS
  • Blastic NK-cell lymphoma with failed remission
  • Blastic plasmacytoid dendritic cell neoplasm (BPDCN) NOS
  • Blastic plasmacytoid dendritic cell neoplasm (BPDCN) not having achieved remission
  • Blastic plasmacytoid dendritic cell neoplasm (BPDCN) with failed remission
C86.4code
Inclusion terms
  • Blastic plasmacytoid dendritic cell neoplasm (BPDCN)
C00-D49chapter
Notes
  • Functional activity
  • All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
  • Morphology [Histology]
  • Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
  • Primary malignant neoplasms overlapping site boundaries
  • A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
  • Malignant neoplasm of ectopic tissue
  • Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).C25.9
Index entries leading here 1
  • Lymphoma (of) (malignant) C85.90
    • blastic NK-cell C86.4
    • blastic plasmacytoid dendritic cell neoplasm (BPDCN) C86.4
Alongside this code 1 same parent — C86.4
Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

CMS22HCC10 CMS28HCC19 ESRD21HCC10 ESRD24HCC10 RX08HCC21

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
yes
Code set
FY2026
Parent
C86.4
Block
C00-C96
Siblings
1

Present FY2025–FY2027.